-
EP1985631
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1985631
| EP1985631 - Demannosylated recombinant factor VIII for the treatment of patients with hemophiila A [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.12.2011 Database last updated on 19.10.2024 | Most recent event Tooltip | 02.12.2011 | Application deemed to be withdrawn | published on 04.01.2012 [2012/01] | Applicant(s) | For all designated states LFB Biotechnologies 3 Avenue des Tropiques 91940 Les Ulis / FR | For all designated states Institut National de la Santé et de la Recherche Médicale 101, rue de Tolbiac 75654 Paris Cedex 13 / FR | [N/P] |
| Former [2008/48] | For all designated states LFB Biotechnologies 3 Avenue des Tropiques 91940 Les Ulis / FR | ||
| For all designated states Institut National de la Santé et de la Recherche Médicale 101, Rue de Tolbiac 75654 Paris Cedex 13 / FR | |||
| Former [2008/44] | For all designated states LFB Biotechnologies 3 Avenue des Tropiques 91940 Les Ulis / FR | ||
| For all designated states Institut National de la Santé et de la Recherche Médicale UMR 872 (équipe 16) Centre de Recherche des Cordeliers 15, rue de l'Ecole de Médecine 75006 Paris / FR | Inventor(s) | 01 /
Chtourou, Abdessatar Sami 20 avenue du Chateau 78990 Elancourt / FR | 02 /
Desmazes, Sebastien Lacroix 5 Promenade Robinson 92130 Issy-les-Moulineaux / FR | 03 /
Kaveri, Srinavas 15 rue Gerber 92240 Malakoff / FR | 04 /
Dasgupta, Suryasarathi, Brigham and Women's Hospital Channing Lab., 6th Floor, 181 Longwood Avenue Boston, MA 02115 / US | 05 /
Bayry, Jagaadeesh 4 Promenade Robinson 92130 Issy-les-Moulineaux / FR | [2008/44] | Representative(s) | Hirsch & Associés 154 Boulevard Haussmann 75008 Paris / FR | [N/P] |
| Former [2008/44] | Hirsch & Associés 58, avenue Marceau 75008 Paris / FR | Application number, filing date | 07290495.6 | 20.04.2007 | [2008/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1985631 | Date: | 29.10.2008 | Language: | EN | [2008/44] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.10.2007 | Classification | IPC: | C07K14/755, A61K38/37, C12N15/12 | [2011/08] | CPC: |
C07K14/755 (EP,KR,US);
A61K38/37 (KR);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
A61P7/04 (EP);
|
| Former IPC [2008/44] | C07K14/755, C12N15/12, A61K38/37, C12P21/00, // C12N5/10, C12N1/21, C12N1/15, A01K67/027 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2008/44] | Title | German: | Entmannosierter rekombinanter Faktor VIII zur Behandlung von Patienten mit Hämophilie A | [2008/44] | English: | Demannosylated recombinant factor VIII for the treatment of patients with hemophiila A | [2008/44] | French: | Facteur VIII recombinant demannosylé pour le traitement de patients atteints de l'hémophilie A | [2008/44] | Examination procedure | 29.04.2009 | Examination requested [2009/24] | 10.06.2009 | Despatch of a communication from the examining division (Time limit: M06) | 18.12.2009 | Reply to a communication from the examining division | 12.04.2010 | Despatch of a communication from the examining division (Time limit: M06) | 07.10.2010 | Reply to a communication from the examining division | 28.02.2011 | Communication of intention to grant the patent | 11.07.2011 | Fee for grant paid | 11.07.2011 | Fee for publishing/printing paid | 12.07.2011 | Application deemed to be withdrawn, date of legal effect [2012/01] | 17.08.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2012/01] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.06.2009 | Fees paid | Renewal fee | 28.04.2009 | Renewal fee patent year 03 | 03.05.2010 | Renewal fee patent year 04 | 02.05.2011 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [DX]US5633150 (WOOD WILLIAM I [US], et al) [DX] 21 * abstract *; | [X]WO02096454 (D COLLEN RES FOUNDATION VZW [BE], et al) [X] 3,10,21-34 * abstract *; | [A]US6759216 (LOLLAR JOHN S [US]) [A] 1-34 * the whole document *; | [X]US2005100990 (SAENKO EVGUENI L [US], et al) [X] 1-3,6,7,10,21-34 * the whole document *; | [X] - MIAO HONGZHI Z ET AL, "Bioengineering of coagulation factor VIII for improved secretion", BLOOD, (20040501), vol. 103, no. 9, ISSN 0006-4971, pages 3412 - 3419, XP002452857 [X] 1,2,6,7,10,21-34 * the whole document * DOI: http://dx.doi.org/10.1182/blood-2003-10-3591 | [X] - BARROW RACHEL T ET AL, "Antigenicity of putative phospholipid membrane-binding residues in factor VIII", BLOOD, (20010101), vol. 97, no. 1, ISSN 0006-4971, pages 169 - 174, XP002452858 [X] 3,10,21-34 * abstract * DOI: http://dx.doi.org/10.1182/blood.V97.1.169 | [A] - BOVENSCHEN N ET AL, "The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor.", JOURNAL OF THROMBOSIS AND HAEMOSTASIS : JTH JUN 2005, (200506), vol. 3, no. 6, ISSN 1538-7933, pages 1257 - 1265, XP002452859 [A] 1-34 * abstract * DOI: http://dx.doi.org/10.1111/j.1538-7836.2005.01389.x | [A] - SAENKO E L ET AL, "The future of recombinant coagulation factors", JOURNAL OF THROMBOSIS AND HAEMOSTASIS, BLACKWELL PUBLISHING, OXFORD, GB, (200305), vol. 1, no. 5, ISSN 1538-7933, pages 922 - 930, XP002320944 [A] 1-34 * the whole document * DOI: http://dx.doi.org/10.1046/j.1538-7836.2003.00196.x | [PX] - DASGUPTA SURYASARATHI ET AL, "A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+T lymphocytes", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, online, (20070514), vol. 104, no. 21, ISSN 0027-8424, pages 8965 - 8970, XP002452860 [PX] 1-34 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.0702120104 |